Apollomics (APLM) Stock Chart & Stock Price History → America could fall from this event (From Porter & Company) (Ad) Free APLM Stock Alerts $0.34 -0.03 (-8.04%) (As of 05/13/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Apollomics Stock Price Performance5 Day Performance-13.51%1 Month Performance-38.67%3 Month Performance-50.33%6 Month Performance-60.57%Year-To-Date Performance-64.46%1 Year Performance-92.73% Receive APLM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Apollomics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceYour Portfolio’s Shield Against Inflation: Gold’s Surge and AI BreakthroughsWhile gold may be thanking China for its recent growth, this sector is currently thanking Elon Musk. As crazy as it sounds, artificial intelligence just got one step closer to ushering in "the next step in human evolution"... and minting new millionaires. And it's all thanks to Musk's latest AI creation.Click to watch this device in action APLM Stock Chart for Tuesday, May, 14, 2024 APLM Chart by TradingView Apollomics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/13/2024$0.37$0.34-7.77%$0.38$0.31430,006 shs$30.70 million05/10/2024$0.40$0.37-7.39%$0.42$0.36199,597 shs$32.87 million05/09/2024$0.41$0.40-2.29%$0.42$0.39153,600 shs$35.49 million05/08/2024$0.40$0.41+0.89%$0.42$0.4067,235 shs$36.33 million05/07/2024$0.41$0.40-0.67%$0.42$0.4044,625 shs$36.01 million05/06/2024$0.40$0.41+2.14%$0.42$0.39198,553 shs$36.25 million Get the Latest News and Ratings for APLM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Apollomics and its competitors with MarketBeat's FREE daily newsletter. 05/03/2024$0.41$0.40-3.29%$0.44$0.39180,001 shs$35.49 million05/02/2024$0.42$0.41-2.15%$0.42$0.40150,988 shs$36.70 million05/01/2024$0.43$0.42-1.64%$0.45$0.4096,587 shs$37.50 million04/30/2024$0.44$0.43-3.18%$0.45$0.40211,354 shs$38.13 million04/29/2024$0.45$0.44-2.22%$0.49$0.42247,864 shs$39.38 million04/26/2024$0.47$0.45-4.46%$0.49$0.43245,149 shs$40.28 million04/25/2024$0.46$0.47+2.50%$0.53$0.46967,025 shs$42.15 million04/24/2024$0.48$0.46-3.87%$0.48$0.40168,941 shs$41.13 million04/23/2024$0.48$0.48+0.63%$0.49$0.46137,758 shs$42.78 million04/22/2024$0.47$0.48+0.64%$0.48$0.4548,301 shs$42.51 million04/19/2024$0.51$0.47-7.45%$0.51$0.46182,365 shs$42.24 million04/18/2024$0.53$0.51-3.77%$0.56$0.51100,685 shs$45.65 million04/17/2024$0.54$0.53-1.87%$0.57$0.5299,894 shs$47.44 million04/16/2024$0.56$0.54-3.55%$0.58$0.52121,341 shs$48.34 million04/15/2024$0.56$0.56+0.13%$0.59$0.55147,930 shs$50.12 million04/12/2024$0.56$0.56-0.41%$0.59$0.55101,448 shs$50.06 million04/11/2024$0.56$0.56+0.38%$0.59$0.55112,832 shs$50.26 million04/10/2024$0.57$0.56-1.50%$0.58$0.55161,865 shs$50.08 million04/09/2024$0.57$0.57+0.11%$0.60$0.55155,325 shs$50.84 million04/08/2024$0.58$0.57-1.49%$0.60$0.56202,672 shs$50.78 million04/05/2024$0.61$0.58-5.56%$0.61$0.5794,560 shs$49.99 million04/04/2024$0.60$0.61+1.65%$0.63$0.57187,808 shs$52.94 million04/03/2024$0.67$0.60-10.71%$0.67$0.60259,011 shs$52.08 million04/02/2024$0.69$0.67-1.93%$0.71$0.6782,215 shs$58.33 million04/01/2024$0.75$0.69-8.64%$0.73$0.65285,664 shs$59.48 million03/29/2024$0.75$0.75$0.75$0.55496,715 shs$65.10 million03/28/2024$0.61$0.75+23.97%$0.75$0.55487,657 shs$65.10 million03/27/2024$0.55$0.61+10.02%$0.62$0.54301,808 shs$52.51 million03/26/2024$0.58$0.55-4.86%$0.61$0.52347,743 shs$47.73 million03/25/2024$0.60$0.58-3.83%$0.63$0.55401,765 shs$50.17 million03/22/2024$0.60$0.61+1.68%$0.63$0.59139,060 shs$52.95 million03/21/2024$0.60$0.60$0.63$0.6074,195 shs$52.07 million03/20/2024$0.60$0.60-0.02%$0.63$0.58104,836 shs$52.07 million03/19/2024$0.61$0.60-0.83%$0.62$0.5961,547 shs$52.08 millionAmerica’s worst nightmare? (Ad)What This Group Has Planned for the 2024 Election Will Shock You Controversial new exposé reveals what’s really going on in America, what it means for your money, and what you must do to protect your assets before it’s too late.Click here to watch this bombshell exposé now.03/18/2024$0.60$0.61+0.67%$0.64$0.5972,587 shs$52.51 million03/15/2024$0.58$0.60+3.62%$0.64$0.58161,426 shs$52.16 million03/14/2024$0.58$0.58-0.65%$0.63$0.57447,399 shs$50.34 million03/13/2024$0.71$0.58-17.89%$0.71$0.58197,571 shs$50.67 million03/12/2024$0.75$0.71-4.69%$0.75$0.6893,871 shs$61.72 million03/11/2024$0.75$0.75+0.13%$0.76$0.7373,440 shs$64.75 million03/08/2024$0.72$0.75+2.90%$0.76$0.7168,782 shs$64.67 million03/07/2024$0.74$0.72-1.56%$0.76$0.72101,554 shs$62.84 million03/06/2024$0.75$0.74-1.80%$0.76$0.73115,592 shs$63.84 million03/05/2024$0.77$0.75-2.60%$0.77$0.7374,691 shs$65.01 million03/04/2024$0.76$0.77+1.18%$0.81$0.70150,296 shs$66.75 million03/01/2024$0.75$0.76+1.47%$0.76$0.74113,363 shs$65.97 million02/29/2024$0.69$0.75+8.71%$0.77$0.70267,119 shs$65.01 million02/28/2024$0.69$0.69+0.57%$0.71$0.67131,225 shs$59.81 million02/27/2024$0.70$0.69-2.13%$0.72$0.68121,245 shs$59.47 million02/26/2024$0.70$0.70+0.14%$0.70$0.6795,123 shs$60.76 million02/23/2024$0.66$0.70+6.07%$0.74$0.65224,116 shs$60.67 million02/22/2024$0.67$0.66-1.35%$0.68$0.6563,932 shs$57.20 million02/21/2024$0.65$0.67+2.61%$0.68$0.6452,662 shs$57.98 million02/20/2024$0.62$0.65+5.17%$0.68$0.63190,972 shs$56.51 million02/19/2024$0.62$0.62$0.66$0.60230,100 shs$53.73 million02/16/2024$0.66$0.62-6.69%$0.66$0.60228,080 shs$53.73 million02/15/2024$0.69$0.66-3.94%$0.69$0.63199,817 shs$57.58 million02/14/2024$0.68$0.69+1.71%$0.69$0.63228,335 shs$59.94 million02/13/2024$0.70$0.68-2.97%$0.71$0.66107,720 shs$58.94 million Related Companies: ProMIS Neurosciences Stock Chart Marker Therapeutics Stock Chart CASI Pharmaceuticals Stock Chart BriaCell Therapeutics Stock Chart JanOne Stock Chart DURECT Stock Chart Fortress Biotech Stock Chart ImmunoPrecise Antibodies Stock Chart Spruce Biosciences Stock Chart Viracta Therapeutics Stock Chart Receive APLM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Apollomics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:APLM) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsThis 1 Biotech Stock has been shocking the marketsHuge AlertsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlaceCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apollomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.